Blog

Centaur AI Series A Announcement

Author Image
Erik Duhaime, Co-founder and CEO
September 3, 2021

Centaur Announces $15M Series A

We are humbled and excited to share our recent $15M Series A funding round led by Matrix Partners! We’re thankful to Matrix and our other investors in this round including Accel, Global Founders Capital, Susa Ventures, Y Combinator, Omega Venture Partners, and other individual investors. We’d also like to thank all of our advisors, partners, and customers for their support.


Our beginnings

One of our core values at Centaur Labs is “Every Voice Counts.” This value is not only central to our company culture but also to our company history, our DNA. Our approach is based on Erik's PhD research at MIT’s Center for Collective Intelligence. The idea is that multiple opinions combined intelligently are going to be more accurate than any single opinion alone. Applying this theory to medicine and AI, we’re leveraging a network of medical experts and performance assessments to label training data. Our mission is to annotate the world’s medical data accurately so that medical AI can make the impact it’s destined to. When we first started about 2 years ago, we were collecting ~160,000 opinions per week. Today, we’re at 1 million!


Our goals moving forward

Our Series A funding enables us to continue our work by growing our team (engineering, data science, marketing, and sales) and continuing to invest in our network of medical experts. 


We’re thrilled to continue on our journey to build a global network of people and machines that are trusted based on their performance to solve medical problems.


Read more about our Series A funding round at Forbes here.


Schedule a demo with Centaur.ai

Related posts

December 8, 2020

When Medical Experts Disagree: AI Training Data | Centaur AI

Learn the how to mitigate the impact of medical error in your data labeling pipeline by intelligently aggregating multiple expert opinions together

Continue reading →
November 22, 2022

RSNA 2022: Clinical AI Safety at Scale

Centaur Labs explores the importance of ensuring clinical AI safety at scale, offering insights on building trustworthy healthcare technologies.

Continue reading →
March 16, 2026

Your Annotation is Good Enough for R&D, but not for the FDA.

Medical AI annotation pipelines often work well for research but fail under FDA scrutiny. Regulators expect documented multi-expert consensus, transparent disagreement resolution, and full annotation provenance. Workflows that rely on single annotators or simple tiebreakers may produce accurate labels but lack the auditability required for regulatory clearance and clinical deployment.

Continue reading →